Immunoglobulin support for patients with hematologic malignancies: when should you discuss starting, how should you dose, and when is it safe to consider stopping
This webinar will provide an immunoglobulin update for secondary hypogammaglobulinemia patients and will cover evidence from clinical trials. This webinar is supported by a grant from Grifols and the Canadian Hematology Society Scientific Planning Committee has planned it to achieve scientific